TITLE

C05 TP53 R72P polymorphism as a modifier of age at onset of Huntington's disease

AUTHOR(S)
Tunali, N E; Acar-Hazer, A; Erginel-Unaltuna, N; Hanagasi, H A
PUB. DATE
September 2010
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background The size of the CAG repeat tract is the major determinant of age of onset (AO) in Huntington's disease (HD). However, the number of the CAG repeats does not allow an accurate prediction of AO; only 30–70% of the variance in AO can be explained by the repeat size alone. R72P polymorphism in the TP53 gene is one of the strong candidate modifiers since this polymorphism alters the function of the p53 protein which interacts with mutant huntingtin and is involved in apoptotic cell death. Aim We aimed to analyse the contribution of TP53 R72P polymorphisms to the AO of Turkish HD patients. Methods DNA samples of 102 unrelated HD patients and 102 healthy age and sex matched controls were genotyped. GRIN genotyping was performed with RFLP analysis. Hardy–Weinberg test statistics were computed for each SNP. The odds ratios and independent sample t tests for genotypes were computed for association of genotypes with AO. Results We demonstrated that TP53 R72P polymorphism can explain 2.9% of the variation observed in onset age and 4.98% of the variation that is not attributable to CAG repeat size in our population. Conclusions An association between the TP53 R72P polymorphism and AO of Indian HD patients was recently reported. However, the following replication studies could not confirm this result. In this study, we presented supporting data for the original investigation and demonstrated that the TP53 gene can be regarded as a modifier for Turkish HD patients.
ACCESSION #
66321976

 

Related Articles

  • Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s disease. Metzger, Silke; Bauer, Peter; Tomiuk, Jürgen; Laccone, Franco; DiDonato, Stefano; Gellera, Cinzia; Mariotti, Caterina; Lange, Herwig; Weirich-Schwaiger, Helga; Wenning, Gregor; Seppi, Klaus; Melegh, Bela; Havasi, Viktoria; Balikó, Laszlo; Wieczorek, Stefan; Zaremba, Jacek; Hoffman-Zacharska, Dorota; Sulek, Anna; Basak, A.; Soydan, Esra // Human Genetics;Sep2006, Vol. 120 Issue 2, p285 

    The expansion of a polymorphic CAG repeat in the HD gene encoding huntingtin has been identified as the major cause of Huntington’s disease (HD) and determines 42–73% of the variance in the age-at-onset of the disease. Polymorphisms in huntingtin interacting or associated genes are...

  • The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients. Metzger, Silke; Walter, Carolin; Riess, Olaf; Roos, Raymund A. C.; Nielsen, Jørgen E.; Craufurd, David; Nguyen, Huu Phuc // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The cause of Huntington disease (HD) is a polyglutamine repeat expansion of more than 36 units in the huntingtin protein, which is inversely correlated with the age at onset of the disease. However, additional genetic factors are believed to modify the course and the age at onset of HD....

  • The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington’s disease. Metzger, Silke; Bauer, Peter; Tomiuk, Juergen; Laccone, Franco; Didonato, Stefano; Gellera, Cinzia; Soliveri, Paola; Lange, Herwig; Weirich-Schwaiger, Helga; Wenning, Gregor; Melegh, Bela; Havasi, Victoria; Balikó, Lazlo; Wieczorek, Stefan; Arning, Larissa; Zaremba, Jacek; Sulek, Anna; Hoffman-Zacharska, Dorota; Basak, A.; Ersoy, Nagehan // Neurogenetics;Mar2006, Vol. 7 Issue 1, p27 

    An expanded polyglutamine stretch in the huntingtin protein has been identified as the pathogenetic cause of Huntington's disease (HD). Although the length of the expanded polyglutamine repeat is inversely correlated with the age-at-onset, additional genetic factors are thought to modify the...

  • PGC-1alpha as modifier of onset age in Huntington disease. Taherzadeh-Fard, Elahe; Saft, Carsten; Andrich, Jürgen; Wieczorek, Stefan; Arning, Larissa // Molecular Neurodegeneration;2009, Vol. 4, p1 

    Although there is a strong correlation between CAG repeat length and age at onset (AO) of motor symptoms, individual Huntington disease (HD) patients may differ dramatically in onset age and disease manifestations despite similar CAG repeat lengths. This has led to a search for genetic factors...

  • C10 Duo as a potential genetic modifier of Huntington's disease. Tsai, Y-C; Soehn, A S; Metzger, S; Nguyen, H P // Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA19 

    Huntington's disease (HD) is a neurodegenerative disorder caused by expansion of the polyglutamine (CAG) tract in the huntingtin (Htt) protein. The length of the CAG repeat is the main predictor of disease onset but only part of the variance is correlated with the age at onset (AAO). We...

  • No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. Mai, Maren; Akkad, Amer D; Wieczorek, Stefan; Saft, Carsten; Andrich, Jürgen; Kraus, Peter H; Epplen, Jörg T; Arning, Larissa // BMC Medical Genetics;2006, Vol. 7, p1 

    Background: Recent evidence suggests that brain-derived neurotrophic factor (BDNF) is an attractive candidate for modifying age at onset (AO) in Huntington disease (HD). In particular, the functional Val66Met polymorphism appeared to exert a significant effect. Here we evaluate BDNF variability...

  • Clinical and genetic features of Huntington disease in Sri Lanka. Sumathipala, Dulika S.; Jayasekara, Rohan W.; Dissanayake, Vajira H. W. // BMC Neurology;2013, Vol. 13 Issue 1, p1 

    Background Huntington disease was one of the first neurological hereditary diseases for which genetic testing was made possible as early as 1993. The study describes the clinical and genetic characteristics of patients with Huntington disease in Sri Lanka. Methods Data of 35 consecutive patients...

  • Choreatische Bewegungsst�rungen. Kosinski, C.M.; Landwehrmeyer, B. // Nervenarzt;Sep2007, Vol. 78 Issue 0, p37 

    The differential diagnosis of chorea includes a growing number of rare diseases. This article gives hints on clinical differences and possible laboratory investigations which may help to identify the underlying disease. The majority of hereditary chorea cases are caused by Huntington's disease....

  • Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. Andresen, J. M.; Gayán, J.; Chemy, S. S.; Brocklebank, D.; Alkorta-Aranburu, G.; Addis, E. A.; Cardon, I. R.; Housman, D. E.; Wexler, N. S. // Journal of Medical Genetics;Jan2007, Vol. 44 Issue 1, p44 

    Background: The major determinant of age of onset in Huntington's disease is the length of the causative triplet CAG repeat. Significant variance remains, however, in residual age of onset even after repeat length is factored out. Many genetic polymorphisms have previously shown evidence of...

  • Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Ramos, Eliana; Latourelle, Jeanne; Gillis, Tammy; Mysore, Jayalakshmi; Squitieri, Ferdinando; Pardo, Alba; Donato, Stefano; Gellera, Cinzia; Hayden, Michael; Morrison, Patrick; Nance, Martha; Ross, Christopher; Margolis, Russell; Gomez-Tortosa, Estrella; Ayuso, Carmen; Suchowersky, Oksana; Trent, Ronald; McCusker, Elizabeth; Novelletto, Andrea; Frontali, Marina // Neurogenetics;Nov2013, Vol. 14 Issue 3/4, p173 

    Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, cognitive, and behavioral disturbances. It is caused by the expansion of the HTT CAG repeat, which is the major determinant of age at onset (AO) of motor symptoms. Aberrant function of N-methyl- D-aspartate...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics